首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1542630

全球生物反應器和發酵槽市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Bioreactors and Fermenters Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球生物反應器和發酵槽市場需求預計將從2023年的40.9147億美元達到2032年的近121.1587億美元，2024-2032年研究期間的複合年成長率為12.82%。

生物反應器和發酵槽在受控條件下培養微生物或細胞以生產生物產品。生物反應器提供了一個可以有效生物反應的環境，促進發酵、細胞培養和組織工程過程。發酵槽是生物反應器的一種，透過管理溫度、pH 值和氧氣水平等變數來專門支持發酵過程，以最佳化微生物生長和產品產量。這兩個系統在製藥、生技和食品生產產業都至關重要。它們可以生產生物製藥、酵素和生物燃料等產品。生物反應器和發酵槽技術的進步，包括自動化和製程控制的改進，提高了生產力和可擴展性，反映了它們在現代生物製造和研究應用中的關鍵作用。

市場動態

由於生物製藥需求不斷成長，生物反應器和發酵槽市場正在強勁成長，需要先進的生物反應器技術來進行大規模生產。慢性病盛行率的上升和對個人化醫療的關注推動了對生物製藥的需求，從而增加了對滿足嚴格生產要求的高效生物反應器系統的需求。生物反應器設計的技術進步，包括自動化、即時監控和製程控制的創新，正在創造重大機會。這些進步提高了製程效率，降低了營運成本，並提高了產品一致性，使生物反應器和發酵槽對各種應用更具吸引力。例如，整合先進的感測器和資料分析可以更精確地控制生物過程，從而提高產量並提高產品品質。

不斷擴大的生物技術和製藥行業正在推動市場成長。包括單株抗體和基因療法在內的新生物製劑的開發需要能夠支援複雜生產過程的複雜生物反應器系統。此外，細胞和基因治療市場的成長為生物反應器應用提供了新的機會，因為這些療法需要專門的設備進行細胞培養和擴增。生物反應器在食品和飲料行業中用於生產益生菌、酵素和發酵產品。消費者對天然和健康食品的偏好日益增加，推動了對生物技術製程的需求，從而推動了生物反應器市場的成長。新興市場也透過投資生物製造基礎設施和採用先進的生物反應器技術來支持當地產業需求，從而促進市場成長。然而，先進生物反應器和發酵槽的初始資本投資和維護成本較高，可能會抑制市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球生物反應器和發酵槽市場的每個細分市場進行了包容性評估。生物反應器和發酵槽產業的成長和趨勢為本研究提供了整體方法。

市場區隔

生物反應器和發酵槽市場報告的這一部分提供了國家和區域層面的細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

依產品類型

免洗生物反應器
多用途生物反應器

按流程

聯準會批次
連續的
批次

按最終用戶

生物製藥公司
合約研究組織
學術及研究機構

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲生物反應器和發酵槽市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。生物反應器和發酵槽市場的主要參與者包括Applikon Biotechnology BV、Finesse Solutions Inc、Danaher Corporation、PBS Biotech Inc.、Eppendorf AG、Sartorius AG、GE Healthcare、Zeta Holding GmbH、Pierre Guerin Technologies、Solaris Biotechnology Srl、Merck KGaA、 Thermo Fisher Scientific Inc. 本部分包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：生物反應器和發酵槽公司的競爭格局

生物反應器和發酵槽市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Applikon Biotechnology BV

公司概況
公司收入
產品
最新動態

Finesse Solutions Inc

公司概況
公司收入
產品
最新動態

Danaher Corporation

公司概況
公司收入
產品
最新動態

PBS Biotech Inc.

公司概況
公司收入
產品
最新動態

Eppendorf AG

公司概況
公司收入
產品
最新動態

Sartorius AG

公司概況
公司收入
產品
最新動態

GE Healthcare

公司概況
公司收入
產品
最新動態

Zeta Holding GmbH

公司概況
公司收入
產品
最新動態

Pierre Guerin Technologies

公司概況
公司收入
產品
最新動態

Solaris Biotechnology Srl

公司概況
公司收入
產品
最新動態

Merck KGaA

公司概況
公司收入
產品
最新動態

Thermo Fisher Scientific Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11214500

The global demand for Bioreactors and Fermenters Market is presumed to reach the market size of nearly USD 12115.87 Million by 2032 from USD 4091.47 Million in 2023 with a CAGR of 12.82% under the study period 2024-2032.

Bioreactors and fermenters cultivate microorganisms or cells to produce biological products under controlled conditions. Bioreactors provide an environment where biological reactions can occur efficiently, facilitating fermentation, cell culture, and tissue engineering processes. Fermenters, a type of bioreactor, specifically support fermentation processes by managing variables like temperature, pH, and oxygen levels to optimize microbial growth and product yield. Both systems are crucial in pharmaceuticals, biotechnology, and food production industries. They enable the production of biopharmaceuticals, enzymes, and biofuels, among other products. Bioreactor and fermenter technology advancement, including automation and process control improvements, enhances productivity and scalability, reflecting their critical role in modern biomanufacturing and research applications.

Market Dynamics

The bioreactors and fermenters market is witnessing robust growth fuelled by the rising demand for biopharmaceuticals, necessitating advanced bioreactor technologies for large-scale production. The rising prevalence of chronic diseases and the focus on personalized medicine fuel the need for biopharmaceuticals, thus boosting demand for efficient bioreactor systems that meet stringent production requirements. Technological advancements in bioreactor design, including innovations in automation, real-time monitoring, and process control, are creating significant opportunities. These advancements enhance process efficiency, reduce operational costs, and improve product consistency, making bioreactors and fermenters more attractive for various applications. For instance, integrating advanced sensors and data analytics enables more precise control of bioprocesses, facilitating higher yields and better-quality products.

The expanding biotechnology and pharmaceutical sectors are propelling market growth. The development of new biologics, including monoclonal antibodies and gene therapies, requires sophisticated bioreactor systems capable of supporting complex production processes. Additionally, the growth of the cell and gene therapy market presents new opportunities for bioreactor applications, as these therapies require specialized equipment for cell culture and expansion. Bioreactors are used in the food & beverage industry to produce probiotics, enzymes, and fermentation products. The increasing consumer preference for natural and health-oriented food products drives the demand for biotechnological processes, thereby fueling the growth of the bioreactor market. Emerging markets also contribute to market growth by investing in biomanufacturing infrastructure and adopting advanced bioreactor technologies to support local industry needs. However, the high initial capital investment and maintenance costs of advanced bioreactors and fermenters may restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Bioreactors and Fermenters. The growth and trends of Bioreactors and Fermenters industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Bioreactors and Fermenters market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Single-use Bioreactors
Multiple-use Bioreactors

By Process

Fed batch
Continuous
Batch

By End User

Biopharmaceutical companies
CROs
Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Bioreactors and Fermenters market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bioreactors and Fermenters market include Applikon Biotechnology B.V., Finesse Solutions Inc, Danaher Corporation, PBS Biotech Inc., Eppendorf AG, Sartorius AG, GE Healthcare, Zeta Holding GmbH, Pierre Guerin Technologies, Solaris Biotechnology Srl, Merck KGaA, Thermo Fisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BIOREACTORS AND FERMENTERS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Process
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOREACTORS AND FERMENTERS MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Single-use Bioreactors Historic and Forecast Sales By Regions
5.4. Multiple-use Bioreactors Historic and Forecast Sales By Regions

6. GLOBAL BIOREACTORS AND FERMENTERS MARKET ANALYSIS BY PROCESS

6.1. Overview By Process
6.2. Historical and Forecast Data Analysis By Process
6.3. Fed batch Historic and Forecast Sales By Regions
6.4. Continuous Historic and Forecast Sales By Regions
6.5. Batch Historic and Forecast Sales By Regions

7. GLOBAL BIOREACTORS AND FERMENTERS MARKET ANALYSIS BY END USER

7.1. Overview By End User
7.2. Historical and Forecast Data Analysis By End User
7.3. Biopharmaceutical companies Historic and Forecast Sales By Regions
7.4. CROs Historic and Forecast Sales By Regions
7.5. Academic & Research Institutes Historic and Forecast Sales By Regions

8. GLOBAL BIOREACTORS AND FERMENTERS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BIOREACTORS AND FERMENTERS COMPANIES

9.1. Bioreactors and Fermenters Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF BIOREACTORS AND FERMENTERS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Applikon Biotechnology B.V.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Finesse Solutions Inc
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Danaher Corporation
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. PBS Biotech Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Eppendorf AG
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Sartorius AG
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. GE Healthcare
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Zeta Holding GmbH
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Pierre Guerin Technologies
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Solaris Biotechnology Srl
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Merck KGaA
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Thermo Fisher Scientific Inc
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments